Target intelligence / Profile preview

CUB and Sushi multiple domains 1 (CSMD1)

Target
CSMD1
Molecular classification
Complement control protein, Transmembrane protein, Cell adhesion molecule, Other
01

Overview

CSMD1 (CUB and Sushi multiple domains 1) is an unusually large transmembrane protein containing alternating CUB and Sushi (also known as CCP, complement control protein) domains; specifically, it comprises 14 N-terminal CUB domains interspersed with Sushi domains, followed by an additional 15 Sushi domains at the C-terminus[1][2]. CSMD1 is expressed at high levels in the brain and is involved in inhibiting the classical and lectin pathways of complement activation by promoting factor I–mediated degradation of C4b and C3b and blocking the membrane attack complex (MAC) formation[2][4]. CSMD1 has a tumor-suppressor function in several cancers, with loss or reduction promoting cell migration, invasion, and carcinogenesis[1][5]. In the CNS, CSMD1 regulates synaptic pruning and neurodevelopment, and genetic variants are associated with increased risk for schizophrenia, intellectual disability, autism, and other neuropsychiatric diseases[3][4]. CSMD1’s levels in serum and mRNA have shown promise as biomarkers for psychosis and cancer prognosis[3]. Overall, CSMD1 is a multifunctional transmembrane complement regulator with emerging roles in immunology, neurodevelopment, and oncology.

Other names
CSMD1PPP1R24CUB and Sushi domain-containing protein 1
02

Mechanism of action

Mechanisms involve inhibition of complement protein deposition and assembly, notably Factor I–mediated degradation of C3b and C4b, and inhibition of membrane attack complex (MAC) formation at C7

03

Biological functions

Complement inhibition (factor I-mediated degradation of C3b and C4b; inhibition of membrane attack complex formation)Regulation of synaptic pruning and neural development in CNSCell adhesionModulation of cell proliferation, migration, and invasion
04

Disease associations

Cancer (head and neck carcinoma, invasive breast cancer, oral and oropharyngeal squamous cell carcinoma)Neurodevelopmental disorders (global developmental delay, intellectual disability, microcephaly, polymicrogyria)Neuropsychiatric disorders (schizophrenia, bipolar disorder, depression, Alzheimer's, Parkinson's, autism spectrum disorder)
05

Safety considerations

Therapeutic targeting of CSMD1 may impact complement activation, potentially increasing risk for infections or affecting normal synaptic pruning and neurodevelopment, posing neurological risksOff-target effects and immune-modulation–related toxicities are theoretical concerns
06

Interacting drugs

Complement inhibitors (e.g., drugs modulating C3, C4, or complement signaling)
07

Biomarkers

CSMD1 mRNA and protein levels have been proposed as biomarkers for early diagnosis of schizophrenia in high-risk individuals and for cancer cell behaviorDecreased CSMD1 expression correlates with schizophrenia risk and invasive cancer phenotypes

Beyond the preview

Go deeper on CUB and Sushi multiple domains 1 (CSMD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CUB and Sushi multiple domains 1 (CSMD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call